LOVE TED W — SEC Form 4 filings
SEC reporting owner CIK 1188919. 13 Form 4 filings on record with FilingPulse; latest filed 2026-09-02.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-02-06 to 2026-09-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | Director | 4 | — | — | 8 |
| Jazz Pharmaceuticals plc (JAZZ) | Director | 3 | — | — | 4 |
| Royalty Pharma plc (RPRX) | Director | 3 | — | — | 3 |
| Structure Therapeutics Inc. (GPCR) | Director | 3 | — | — | 3 |
Form 4 filings — LOVE TED W
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-02 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Tax withholding (F): 6 @ $244.06 · Tax withholding (F): 737 @ $241.39 | EDGAR |
| 2026-08-07 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 1,605 @ $0 | EDGAR |
| 2026-06-18 | 4 | Structure Therapeutics Inc. (GPCR) | Grant/award (A): 39,453 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | Royalty Pharma plc (RPRX) | Grant/award (A): 4,545 @ $0 | EDGAR |
| 2026-05-04 | 4 | GILEAD SCIENCES, INC. (GILD) | Grant/award (A): 1,146 @ $0 · Grant/award (A): 4,884 (derivative) @ $0 | EDGAR |
| 2026-03-02 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 1,527 @ $0 | EDGAR |
| 2025-06-25 | 4 | Structure Therapeutics Inc. (GPCR) | Grant/award (A): 51,804 (derivative) @ $0 | EDGAR |
| 2025-05-14 | 4 | Royalty Pharma plc (RPRX) | Grant/award (A): 7,614 @ $0 | EDGAR |
| 2025-05-08 | 4 | GILEAD SCIENCES, INC. (GILD) | Grant/award (A): 1,516 @ $0 · Grant/award (A): 6,809 (derivative) @ $0 | EDGAR |
| 2024-06-27 | 4 | Structure Therapeutics Inc. (GPCR) | Grant/award (A): 33,595 (derivative) @ $0 | EDGAR |
| 2024-06-10 | 4 | Royalty Pharma plc (RPRX) | Grant/award (A): 9,293 @ $0 | EDGAR |
| 2024-05-09 | 4 | GILEAD SCIENCES, INC. (GILD) | Grant/award (A): 2,310 @ $0 · Grant/award (A): 12,648 (derivative) @ $0 | EDGAR |
| 2024-02-06 | 4 | GILEAD SCIENCES, INC. (GILD) | Grant/award (A): 512 @ $0 · Grant/award (A): 2,996 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1188919 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →